COVID-19 History
Coronaviruses are not a recent phenomenon. These viruses have been around for a long time. In 1965, specialists at the Common Cold Research Unit in Wiltshire, UK, reported that a boy got infected with a virus B814. They claimed the microorganism as “virtually unrelated to any other known virus of the human respiratory tract.”
In 1966, Dorothy Hamre and John Procknow of the University of Chicago described an infection, which was different from other known respiratory infections.
In 1968, eight researchers proposed that the newly isolated human viruses belong to a new category known as coronaviruses. These viruses have “characteristic fringe of projections, which are rounded or petal shaped…recalling the solar corona.”
In 2003, a group of researchers reported that the outbreak of a new human coronavirus caused severe acute respiratory syndrome (SARS) in late 2002 in southern China.
In 2004, researchers at Erasmus Medical Center in the Netherlands isolated a coronavirus from a child with pneumonia.
In 2005, a group of researchers at the University of Hong Kong reported another coronavirus, HKU1, in samples from two patients with pneumonia.
In 2012, a group of researchers at Erasmus Medical Center discovered a new coronavirus that they named MERS-CoV. They isolated the virus from a man in Saudi Arabia with pneumonia and kidney failure.
In December 2019, a local outbreak of pneumonia, from an unknown origin, was detected in Wuhan (China). It quickly became identified as a new coronavirus outbreak that was named COVID-19, now known as SARS-CoV-2.
In 2020, a team of researchers in China discovered that the virus that caused this outbreak originated in bats and was later transmitted to humans.
As of Feb 17, 2020, the outbreak has spread to every province of mainland China. It has also spread to 27 other countries and regions, and there are over 70.000 confirmed cases of COVID-19.
Compared with the SARS-CoV that caused an outbreak of SARS in 2003, SARS-CoV-2 has a stronger transmission capacity and higher mortality rate. The number of confirmed cases of COVID-19 reached over 63,000,000 and over 1.5 million deaths worldwide as of the end of November 2020, resulting in a fatality rate of approximately 2.5%.
Implementing a lockdown is the best way to stop the spread of the infection. However, governments around the world believe that a lockdown must be utilized efficiently, otherwise it will have a painful impact on the economy.
Another option that can stop the spread of the virus is enforcing a limited lockdown. That makes it conceivable to segregate infected regions where the infection flows quickly. It also allows the government to figure out who is infected with the virus transporters rapidly, so they can apply preventative measures and stop the spread of infection.
Still, many governments do not want to consider the option of a total lockdown facing a second outbreak because a lockdown presents very complicated economic challenges.
As of now, there are 100 COVID-19 vaccine candidates in progress, with some of these in the preliminary human stage. The World Health Organization (WHO) is teaming up with researchers, businesses, and worldwide wellbeing associations to speed up the pandemic response through the Access to COVID-19 Tools (ACT) Accelerator.
The ACT Accelerator is a worldwide collaboration by the WHO, the Global Alliance for Vaccines and Immunizations (GAVI), and the Coalition for Epidemic Preparedness Innovations (CEPI) founded to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
In 2020, the WHO, GAVI, and CEPI founded an initiative focusing solely on developing a COVID-19 vaccine called COVAX. It advocates for the unbiased access and dissemination of these vaccines to secure individuals in all nations. COVAX will prioritize the individuals who are most at risk of contracting the virus.
[0]